WHO ICTRP trial
To evaluate Efficacy and safety of LevodynTM in subjects with mild hypertension
CTRI/2011/09/002028 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2011/09/002028 |
|---|---|
| Public title | To evaluate Efficacy and safety of LevodynTM in subjects with mild hypertension |
| Scientific title | Efficacy and safety of LevodynTM in subjects with mild hypertension: A randomized double-blind placebo-controlled parallel- groups, multi-centre study. - None |
| Primary sponsor | Nathan naturalLLC |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Mild Hypertension |
| Interventions | Intervention1: Levodyn,One tablet twice a day, orally for 3 months: Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B6, Vitamin B9, Vitamin B12, VitaminH/7,Vitamin B5,Calcium,Magnesium,Potassium,Herbal blend per tablet, Asian… |
| Registration date | Sep 29, 2011 |
| Target size | 30 |
| Secondary IDs | NN/110520/LVD/HT |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: